Zuluita, Shairah M.
HRN: 22-35-06 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/22/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
12/22/2022
12/28/2022
IV
350mg
Q6Hrs
PCAP-C; Tc PTB
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes